Furthermore, our study suggests that interleukin-15 (IL-15) promotes the expansion, proliferation, and cytotoxic function of CD4<sup>+</sup>CD28<sup>-</sup> T cells in SLE patients through activation of the Janus kinase3-STAT5 pathway. This evidence concerns the gene CD28 and systemic lupus erythematosus.